Targeting Biotech’s 1%, China Speeds Into Gene Therapy: Gadfly – Washington Post
Washington Post |
Targeting Biotech's 1%, China Speeds Into Gene Therapy: Gadfly
Washington Post China wants to go big on biotech and already is marching into experimental gene therapy. Last year marked a milestone in cancer treatment: In August, the U.S. FDA approved Novartis AG's Kymriah, a CAR-T therapy for children with acute lymphoblastic … |
